Picture of Ocuphire Pharma logo

OCUP Ocuphire Pharma Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Annual balance sheet for Ocuphire Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments12.216.424.842.750.5
Net Total Accounts Receivable
Net Total Receivables4.852.33
Prepaid Expenses
Total Other Current Assets
Total Current Assets12.717.726.14953.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.2790.0140.010.0060
Long Term Investments
Total Assets1317.726.14953.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities2.913.193.852.754.04
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities3.0131.13.852.754.04
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity9.96-13.522.246.249.9
Total Liabilities & Shareholders' Equity1317.726.14953.9
Total Common Shares Outstanding